Company UpdateNewspaper Publication
HealthcarePharmaceuticals & BiotechnologyPharmaceuticals
Phaarmasia Ltd
Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 27 filings·Updated 14 Aug 2026
Showing 10 of 27 filings.
14 Aug 20261 filing
13 Aug 20262 filings
ResultFinancial Results
Phaarmasia Q1 FY27 unaudited: total income 858.46 lakh; net profit 33.90 lakh
Financial results (quarter ended 30 Jun 2026)
- Revenue from operations: 828.33 lakh; other income: 30.13 lakh.
- Total income: 858.46 lakh for quarter ended 30 June 2026.
- Total expenses: 826.02 lakh.
- Net profit for the quarter: 33.90 lakh.
- Basic EPS: 0.50; Diluted EPS: (1.03) Rs.
- Board approved the unaudited results on 13 August 2026.
- Single-segment operations; segment reporting not applicable.
- Auditors conducted a limited review; report placed before the board.
ResultFinancial Results
Phaarmasia Board approves Q1 2026-27 results for quarter ended 30 June 2026; audit review finds no material misstatement.
Results update
- Board approved Q1 2026-27 results for quarter ended 30 June 2026.
- Meeting held on 13 August 2026; results attached and filed.
- Independent auditor's review report states no material misstatement.
10 Aug 20261 filing
Board Meeting
Phaarmasia to hold board meeting on 13 August 2026 to approve unaudited Q1 results and AGM actions
Meeting Details
- Board meeting scheduled for 13 August 2026 at 5:00 PM via Video Conference/AVM.
Key Agenda Items
- To consider unaudited quarterly results for quarter ended 30 June 2026.
- To consider and take note of Limited Review Report for quarter ended 30 June 2026.
- To take note of the Secretarial Audit Report for the FY ended 31 March 2026.
- To consider, review and approve the Directors’ Report for the FY ended 31 March 2026.
- To consider and convene the 45th AGM and fix the date, time and venue.
- To consider and approve the draft Notice for the 45th AGM.
- To consider the appointment of Scrutinizer for Evoting at the 45th AGM.
Other Notes
- Trading window closure periods not specified in filing.
16 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate confirms dematerialisation processing and depository updates within 15 days
Dematerialisation status
- Dematerialisation: securities mutilated and cancelled after verification; NSDL/CDSL updated as registered owner within 15 days.
- Details of dematerialised securities furnished to stock exchanges.
- Securities dematerialised were processed by the RTA within the reporting period.
13 Jun 20261 filing
Company UpdateGeneral
The exchange has sought clarification from Phaarmasia Ltd on 10th June 2026 with reference to significant movement in price, in order to ensure that investors have the latest relevant information ....
17 Apr 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg 74(5) of SEBI(Depositories and Participants) Reg, 2018 for the quarter and Year Ended 31st march 2026.
15 Apr 20262 filings
Company UpdateGeneral
The Exchange has Sought Clarification on Price Movement with reference to Significant Movement in Price, in Order to Ensure that Investors have Latest Information about the company, So ....
Company UpdateChange in Registered Office Address
Intimation of Change in the Registered Office of the Company within the Local Limits of City
13 Apr 20261 filing
Company UpdateClarification
The Exchange has sought clarification from Phaarmasia Ltd on April 13, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant information ....
Showing 10 of 27 filings